37 Recruiting Head and Neck Cancer Phase 2 Clinical Trials
Active phase 2 studies for head and neck cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Head and Neck Cancer studiesPhase 2 Studies for Head and Neck Cancer
Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Imaging With a PET Agent for Detection of Cancers of the Head and Neck
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer
📍 Baptist Alliance MCI — Miami, Florida
View Study & Checklist ➔ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer
📍 Center for Cancer Research — Bethesda, Maryland
View Study & Checklist ➔"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
📍 Stephenson Cancer Center — Oklahoma City, Oklahoma
View Study & Checklist ➔Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
📍 University of Louisville - James Graham Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)
📍 Maryland Proton Treatment Center — Baltimore, Maryland
View Study & Checklist ➔Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
📍 Hoag Hospital — Irvine, California
View Study & Checklist ➔Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
📍 University of San Diego — San Diego, California
View Study & Checklist ➔Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
📍 Universtiy of Colorado Hospital — Aurora, Colorado
View Study & Checklist ➔Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
📍 Mayo Clinic Rochester — Scottsdale, Arizona
View Study & Checklist ➔Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
📍 Providence Portland Medical Center — Portland, Oregon
View Study & Checklist ➔Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
📍 Hoag Hospital — Irvine, California
View Study & Checklist ➔Safety and Efficacy of APG-157 in Head and Neck Cancer
📍 VAGLAHS, West Los Angeles — Los Angeles, California
View Study & Checklist ➔Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
📍 OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma
View Study & Checklist ➔RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
📍 University of Illinois at Chicago — Chicago, Illinois
View Study & Checklist ➔Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
📍 University of Kentucky Markey Cancer Center — Lexington, Kentucky
View Study & Checklist ➔Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
📍 Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
View Study & Checklist ➔PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
📍 London Regional Cancer Program — London, Ontario
View Study & Checklist ➔Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
📍 Miami Cancer Institute — Miami, Florida
View Study & Checklist ➔Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
📍 UT Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔Phase II Panitumumab-IRDye800 in Head & Neck Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ATATcH Alternating Treatment Plans for Advanced Cancer
📍 Trinitas Hospital and Comprehensive Cancer Center — Elizabeth, New Jersey
View Study & Checklist ➔Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
📍 Johns Hopkins Hospital East Baltimore — Baltimore, Maryland
View Study & Checklist ➔Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
📍 University of Cincinnati Medical Center — Cincinnati, Ohio
View Study & Checklist ➔Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
📍 University of North Carolina at Chapel Hill, Department of Radiation Oncology — Chapel Hill, North Carolina
View Study & Checklist ➔Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
📍 Maryland Proton Treatment Center — Baltimore, Maryland
View Study & Checklist ➔